Switching should not be driven by price alone clinical suitability, tolerability and patient preference remain paramount
Key Efficacy Comparison Year 1 Outcomes: For chronic weight management in adults without diabetes, tirzepatide 15 mg achieved a mean 22.5% total body weight reduction in SURMOUNT-1 (N Engl J Med, 2022), while semaglutide 2.4 mg delivered approximately 15% in the STEP program
Reddy's", The Globe and Mail , archived from the original on 29 April 2026 1 2 3 4 "Brazil approves first generic semaglutide pen after Ozempic patent expiry", Reuters website "Brazilian federal court denies semaglutide patent extension"
Symptomatic treatments for neuropathic pain may include medications such as amitriptyline, duloxetine, gabapentin, or pregabalin, as recommended by NICE Clinical Guideline 173 on neuropathic pain management